Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Clene Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −4 vs. Q2 2022
- Shares held
- 4.33M
- +784.0K (+22.1%) vs. Q2 2022
- Total value
- $12.1M
- +$3.16M (+35.4%) vs. Q2 2022
- New holders
- 11
- 8 more added
- Sold out
- 15
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.6M |
| Q1 2026 | 29 | $10.8M |
| Q4 2025 | 28 | $11.4M |
| Q3 2025 | 29 | $4.72M |
| Q2 2025 | 24 | $2.28M |
| Q1 2025 | 24 | $1.40M |
| Q4 2024 | 27 | $2.60M |
| Q3 2024 | 20 | $4.66M |
| Q2 2024 | 37 | $2.40M |
| Q1 2024 | 44 | $3.10M |
| Q4 2023 | 46 | $3.50M |
| Q3 2023 | 47 | $12.3M |
| Q2 2023 | 50 | $28.1M |
| Q1 2023 | 31 | $3.42M |
| Q4 2022 | 35 | $3.09M |
| Q3 2022 | 38 | $12.1M |
| Q2 2022 | 42 | $8.93M |
| Q1 2022 | 53 | $24.7M |
| Q4 2021 | 48 | $26.0M |
| Q3 2021 | 39 | $37.8M |
| Q2 2021 | 35 | $51.6M |
| Q1 2021 | 24 | $31.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Clene Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 15 | $0 | 0.00% | −64,504−100.0% | Reduced |
| Wells Fargo & Company | 134 | $0 | 0.00% | −10−6.9% | Reduced |
| FMR LLC | 247 | $1.00K | 0.00% | −3−1.2% | Reduced |
| US Bancorp | 840 | $2.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 650 | $2.00K | 0.00% | −168−20.5% | Reduced |
| BNP Paribas Arbitrage, SA | 1,000 | $2.80K | 0.00% | +1,000 | New |
| Cutler Group LP | 1,600 | $4.00K | 0.00% | +1,600 | New |
| Washington Trust Co | 2,000 | $6.00K | 0.00% | +1,000+100.0% | Added |
| Parallax Volatility Advisers, L.P. | 2,740 | $8.00K | 0.00% | +2,740 | New |
| Jefferies Group LLC | 4,956 | $13.9K | 0.00% | +4,956 | New |
| Advisor Group Holdings, Inc. | 5,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,482 | $18.0K | 0.00% | −15,929−71.1% | Reduced |
| Bank of America Corp | 6,848 | $19.0K | 0.00% | +757+12.4% | Added |
| Pallas Capital Advisors LLC | 17,341 | $21.0K | 0.00% | +17,341 | New |
| Goldman Sachs Group Inc | 12,944 | $36.0K | 0.00% | −13,201−50.5% | Reduced |
| Morgan Stanley | 13,345 | $37.0K | 0.00% | −48,402−78.4% | Reduced |
| Tower Research Capital LLC (TRC) | 14,378 | $40.0K | 0.00% | +10,147+239.8% | Added |
| XTX Topco Ltd | 19,140 | $54.0K | 0.01% | +19,140 | New |
| Qube Research & Technologies Ltd | 20,749 | $58.0K | 0.00% | +20,749 | New |
| Veritable, L.P. | 25,230 | $71.0K | 0.00% | +5,230+26.2% | Added |
| Oppenheimer & Co Inc | 29,526 | $83.0K | 0.00% | −2,500−7.8% | Reduced |
| Two Sigma Investments, LP | 33,399 | $94.0K | 0.00% | +33,399 | New |
| Citadel Advisors LLC | 36,469 | $102.0K | 0.00% | −28,783−44.1% | Reduced |
| Northern Trust Corp | 37,172 | $104.0K | 0.00% | +1,068+3.0% | Added |
| Royal Bank of Canada | 52,017 | $146.0K | 0.00% | +52,017 | New |
| SRS Capital Advisors, Inc. | 55,250 | $155.0K | 0.02% | 00.0% | Unchanged |
| State Street Corp | 68,046 | $191.0K | 0.00% | 00.0% | Unchanged |
| Caption Management, LLC | 81,718 | $228.0K | 0.04% | +81,718 | New |
| Morgan Jess S & Co Inc | 112,000 | $314.0K | 0.27% | +24,750+28.4% | Added |
| Simplex Trading, LLC | 132,415 | $370.0K | 0.01% | +130,860+8,415.4% | Added |
| BlackRock Inc. | 184,001 | $516.0K | 0.00% | −2,675−1.4% | Reduced |
| Millennium Management LLC | 210,084 | $588.0K | 0.00% | −35,970−14.6% | Reduced |
| Soltis Investment Advisors LLC | 218,920 | $613.0K | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 221,191 | $619.0K | 0.00% | −9,749−4.2% | Reduced |
| Laird Norton Trust Company, LLC | 268,581 | $752.0K | 0.17% | 00.0% | Unchanged |
| Kepos Capital LP | 400,000 | $1.12M | 0.14% | −200,000−33.3% | Reduced |
| Vanguard Group Inc | 931,613 | $2.61M | 0.00% | +119,084+14.7% | Added |
| Tang Capital Management LLC | 1,100,000 | $3.08M | 0.38% | +1,100,000 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −165,180−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −96,741−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,917−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,370−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,470−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,514−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −6,265−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,276−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |